AI assistant
Sending…
Sarepta Therapeutics, Inc. — Director's Dealing 2017
Nov 13, 2017
31721_dirs_2017-11-13_3dfca3e1-a96b-4d2e-8d1f-7cf2e2637999.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Sarepta Therapeutics, Inc. (SRPT)
CIK: 0000873303
Period of Report: 2017-11-08
Reporting Person: INGRAM DOUGLAS S (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-11-08 | Common Stock | P | 38138 | $52.44 | Acquired | 420196 | Direct |
More from Sarepta Therapeutics, Inc.
Regulatory Filings
2026
Jun 4
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 6
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24